Browsing: Cutaneous

This look back at outcomes for 316 patients receiving upfront immune checkpoint inhibition for advanced cutaneous melanoma reports a longer…

The incidence of melanoma in situ is rapidly rising so it’s a good thing this SEER analysisl reports a melanoma-specific…

This Medicare claims data reveals the most common site by far of non-melanoma skin cancers is the head and neck…

The “updated” USPSTF recommendation on annual skin exams for cutaneous cancer prevention is exactly the same as it has been…

Is 8 Gy x 1 an effective palliative regimen for mycosis fungoides (MF)? In this retrospective review, 46 patients with…

Another RELATIVITY trial demonstrates the promise of adding the LAG-3 inhibitor relatlimab to nivolumab for metastatic melanoma, not only upfront,…

  January 03, 2023 Comeback. This huge meta-analysis including more than 125K patients with cutaneous squamous cell carcinoma reports the…

December 13, 2022 Brisket. This retrospective look at 142 cases of metastatic melanoma treated with immune checkpoint inhibition with available…

In case you’re not convinced, another retrospective study, this one looking at 203 patients receiving radiosurgery for 1388 melanoma brain…